These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [ASTRO 2002: results and perspectives for urologic cancers]. Coquard R Prog Urol; 2003 Feb; 13(1):160-2. PubMed ID: 12703375 [No Abstract] [Full Text] [Related]
24. The Road Ahead for Circulating microRNAs in Diagnosis and Management of Testicular Germ Cell Tumors. Lafin JT; Murray MJ; Coleman N; Frazier AL; Amatruda JF; Bagrodia A Mol Diagn Ther; 2021 May; 25(3):269-271. PubMed ID: 33893623 [No Abstract] [Full Text] [Related]
25. The role of immunotherapy for urological tumours. Hrouda D; Muir GH; Dalgleish AG Br J Urol; 1997 Mar; 79(3):307-16. PubMed ID: 9117206 [No Abstract] [Full Text] [Related]
26. A residual mature teratoma with a more balanced karyotype than the primary testicular nonseminoma? Castedo SM; Oosterhuis JW; de Jong B; Seruca R; Dam A; Buist J; Schraffordt Koops H; Sleijfer DT Cancer Genet Cytogenet; 1988 May; 32(1):51-7. PubMed ID: 2833344 [TBL] [Abstract][Full Text] [Related]
28. Plasma Micro-RNA 371 Expression in Early-Stage Germ Cell Tumors: Are We Ready to Move Toward Biology-Based Decision Making? Alsyouf M; Nappi L; Nichols C; Daneshmand S J Clin Oncol; 2023 May; 41(14):2478-2482. PubMed ID: 36758194 [No Abstract] [Full Text] [Related]
29. [Clinical effect of long-term administration of PSK in a combination in patients with malignant urologic cancer]. Niijima T; Koiso K; Ueno A; Kawabe K; Umeda T; Kobayashi K; Akaza H Gan To Kagaku Ryoho; 1982 Mar; 9(3):540-2. PubMed ID: 7184410 [TBL] [Abstract][Full Text] [Related]
30. Molecular and cytogenetic events in urologic tumors. Klein EA; Fair WR; Chaganti RS Semin Urol; 1988 Feb; 6(1):2-21. PubMed ID: 2838875 [No Abstract] [Full Text] [Related]
32. Status and prospects of gene therapy for urologic cancer. Kumon H Mol Urol; 2000; 4(2):39-40. PubMed ID: 12006238 [No Abstract] [Full Text] [Related]
33. [Primary urological cancers in a context of limited resources: Epidemiology and treatment]. Ouedraogo S; Traore MT; Kambire JL; Ouedraogo S; Bere B; Kabore AF Bull Cancer; 2019 Oct; 106(10):868-874. PubMed ID: 31350015 [TBL] [Abstract][Full Text] [Related]
34. [Tumor suppressor genes in human urological malignancies]. Shuin T; Yao M Nihon Hinyokika Gakkai Zasshi; 1995 Jun; 86(6):1073-87. PubMed ID: 7609350 [No Abstract] [Full Text] [Related]
35. Testicular Cancer in Monozygotic Twin Brothers with Urticaria Pigmentosa. Péčová T; Vorčáková K; Žaliová M; Burjanivová T; Malicherová B; Plank L; Trka J; Péčová K; Adamicová K; Péč M; Pec J Acta Derm Venereol; 2018 Apr; 98(5):528-529. PubMed ID: 29230478 [No Abstract] [Full Text] [Related]
36. [Towards the individualisation of prescriptions in oncology: urogenital cancers]. Pouessel D; Culine S Bull Cancer; 2008 Oct; 95(10):975-8. PubMed ID: 19004728 [TBL] [Abstract][Full Text] [Related]
37. [Update on the medical treatment of urologic tumors]. Culine S Bull Cancer; 2000 Jan; 87(1):71-5. PubMed ID: 10673634 [No Abstract] [Full Text] [Related]